Пређи на садржај

Онкологија

Ризици трансфузије и дилеме

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (отвара нови прозор)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Извор‎: Surgery 2012;152(3):344-54.

Индекс‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (отвара нови прозор)

Perioperative blood transfusions promote pancreas cancer progression. (отвара нови прозор)

Benson D, Barnett CC Jr.

Извор‎: J Surg Res 2011;166(2):275-9.

Индекс‎: PubMed 20828757

DOI‎: 10.1016/j.jss.2010.05.059

https://www.ncbi.nlm.nih.gov/pubmed/20828757 (отвара нови прозор)

Impact of allogeneic and autologous transfusion on immune function in patients with tumors. (отвара нови прозор)

Guo JR, Xu F, Jin XJ, Shen HC, Liu Y, Zhang YW, Shao Y.

Извор‎: Asian Pac J Cancer Prev 2014;15(1):467-74.

Индекс‎: PubMed 24528076

https://www.ncbi.nlm.nih.gov/pubmed/24528076 (отвара нови прозор)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (отвара нови прозор)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Извор‎: Ann Med Surg (Lond) 2016;6:6-11.

Индекс‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (отвара нови прозор)

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. (отвара нови прозор)

Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.

Извор‎: Arch Intern Med 2008;168(21):2377-81.

Индекс‎: PubMed 19029504

DOI‎: 10.1001/archinte.168.21.2377

https://www.ncbi.nlm.nih.gov/pubmed/19029504 (отвара нови прозор)

Perioperative blood transfusion, age at surgery, and prognosis in a database of 526 upper gastrointestinal cancers. (отвара нови прозор)

Kosumi K, Baba Y, Harada K, Yoshida N, Watanabe M, Baba H.

Извор‎: Dig Surg 2015;32(6):445-53.

Индекс‎: PubMed 26550999

DOI‎: 10.1159/000433609

https://www.ncbi.nlm.nih.gov/pubmed/26550999 (отвара нови прозор)

Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. (отвара нови прозор)

Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, Zhou Y, Zhou Y, Zhang Y.

Извор‎: PLoS One 2013;8(5):e64261.

Индекс‎: PubMed 23741309

DOI‎: 10.1371/journal.pone.0064261

https://www.ncbi.nlm.nih.gov/pubmed/23741309 (отвара нови прозор)

Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer. (отвара нови прозор)

Melis M, McLoughlin JM, Dean EM, Siegel EM, Weber JM, Shah N, Kelley ST, Karl RC.

Извор‎: J Surg Res 2009;153(1):114-20.

Индекс‎: PubMed 19201421

DOI‎: 10.1016/j.jss.2008.06.005

https://www.ncbi.nlm.nih.gov/pubmed/19201421 (отвара нови прозор)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (отвара нови прозор)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Извор‎: Cancer Treat Rev 2016;46:1-8.

Индекс‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (отвара нови прозор)

Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. (отвара нови прозор)

Schiergens TS, Rentsch M, Kasparek MS, Frenes K, Jauch KW, Thasler WE.

Извор‎: Dis Colon Rectum 2015;58(1):74-82.

Индекс‎: PubMed 25489697

DOI‎: 10.1097/DCR.0000000000000233

https://www.ncbi.nlm.nih.gov/pubmed/25489697 (отвара нови прозор)